ATE67497T1 - Verfahren zur herstellung von thiazolidinedionderivaten. - Google Patents
Verfahren zur herstellung von thiazolidinedionderivaten.Info
- Publication number
- ATE67497T1 ATE67497T1 AT87306425T AT87306425T ATE67497T1 AT E67497 T1 ATE67497 T1 AT E67497T1 AT 87306425 T AT87306425 T AT 87306425T AT 87306425 T AT87306425 T AT 87306425T AT E67497 T1 ATE67497 T1 AT E67497T1
- Authority
- AT
- Austria
- Prior art keywords
- compound
- chem
- formula
- given above
- meaning given
- Prior art date
Links
- 150000001467 thiazolidinediones Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 abstract 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 abstract 1
- 238000010531 catalytic reduction reaction Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000002140 halogenating effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000003461 sulfonyl halides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17427886 | 1986-07-24 | ||
| EP19870306425 EP0257781B1 (de) | 1986-07-24 | 1987-07-20 | Verfahren zur Herstellung von Thiazolidinedion-Derivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE67497T1 true ATE67497T1 (de) | 1991-10-15 |
Family
ID=15975864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87306425T ATE67497T1 (de) | 1986-07-24 | 1987-07-20 | Verfahren zur herstellung von thiazolidinedionderivaten. |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US4812570A (de) |
| EP (1) | EP0257781B1 (de) |
| JP (1) | JP2611244B2 (de) |
| KR (1) | KR950008312B1 (de) |
| AT (1) | ATE67497T1 (de) |
| DE (1) | DE3773089D1 (de) |
| ES (1) | ES2037718T3 (de) |
| GR (1) | GR3003381T3 (de) |
| HU (1) | HU198043B (de) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU203330B (en) * | 1987-06-10 | 1991-07-29 | Pfizer | Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them |
| US4956374A (en) * | 1988-07-29 | 1990-09-11 | Bristol-Myers Company | Polysubstituted thiazolylpyridine carboxyamide antifungal antibiotic |
| GB8919417D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
| US5053420A (en) * | 1989-10-13 | 1991-10-01 | Pershadsingh Harrihar A | Thiazolidine derivatives for the treatment of hypertension |
| EP0454501B1 (de) * | 1990-04-27 | 2001-09-05 | Sankyo Company Limited | Benzylidenthiazolidinderivate, ihre Herstellung und ihre Anwendung als Lipidperoxid-Inhibitoren |
| EP0506273B1 (de) * | 1991-03-25 | 1995-05-31 | Takeda Chemical Industries, Ltd. | Verfahren zur Herstellung von Ethern |
| JP2687811B2 (ja) * | 1991-03-25 | 1997-12-08 | 武田薬品工業株式会社 | エーテル類の製造法 |
| FR2680512B1 (fr) * | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| WO1993013095A1 (en) * | 1991-12-20 | 1993-07-08 | The Upjohn Company | A reduction method for substituted 5-methylene-thiazolidinediones |
| WO1993022445A1 (en) * | 1992-05-05 | 1993-11-11 | The Upjohn Company | A process for producing pioglitazone metabolite |
| US5594015A (en) * | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
| US5952509A (en) * | 1996-06-27 | 1999-09-14 | Takeda Chemical Industries, Ltd. | Production of benzaldehyde compounds |
| TR199903057T2 (xx) * | 1997-06-18 | 2000-04-21 | Smithkline Beecham Plc | Diabetin tiazolidinedion ve metformin ile tedavisi. |
| EP1671637A3 (de) * | 1997-06-18 | 2007-12-19 | SmithKline Beecham P.L.C. | Behandlung der Diabetes mit Thiazolidindione und Sulphonylurea |
| GB9715306D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
| GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
| US7091359B2 (en) | 1997-11-04 | 2006-08-15 | Smithkline Beecham Plc | Process for the preparation of thiazolidinedione derivatives |
| GB9723295D0 (en) | 1997-11-04 | 1998-01-07 | Smithkline Beecham Plc | Novel process |
| GB9726568D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
| DZ2937A1 (fr) | 1998-11-12 | 2004-03-15 | Smithkline Beecham Plc | Compositions nouvelles de sensibilidants à l'insuline. |
| GB9824893D0 (en) * | 1998-11-12 | 1999-01-06 | Smithkline Beckman Corp | Novel method of treatment |
| WO2000028989A1 (en) * | 1998-11-12 | 2000-05-25 | Smithkline Beecham P.L.C. | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| JP2001072592A (ja) | 1999-07-01 | 2001-03-21 | Kyowa Hakko Kogyo Co Ltd | テロメラーゼ阻害剤 |
| ID29875A (id) * | 1999-07-01 | 2001-10-18 | Geron Corp Cs | Penghambat-penghambat telomerase dan metode penggunaannya |
| GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
| US6452014B1 (en) | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
| FR2820742B1 (fr) * | 2001-02-14 | 2005-03-11 | Ppg Sipsy | Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine |
| FR2820741A1 (fr) * | 2001-02-14 | 2002-08-16 | Ppg Sipsy | Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine |
| IL162460A0 (en) * | 2001-12-20 | 2005-11-20 | Teva Pharma | Hydrogenation of precursors to thiazolidinedione antihyperglycemics |
| WO2004000810A1 (en) * | 2002-06-19 | 2003-12-31 | Eos Eczacibasi Ozgun Kimyasal Urunler Sanyi Ve Ticaret A.S. | A process for the production of substituted phenyl ethers |
| US8993773B2 (en) | 2002-07-16 | 2015-03-31 | Cadila Healthcare Limited | Process to prepare pioglitazone via several novel intermediates |
| WO2004007490A2 (en) | 2002-07-16 | 2004-01-22 | Cadila Healthcare Limited | A process to prepare pioglitazone via several intermediates. |
| US7232828B2 (en) * | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
| US20050014767A1 (en) * | 2003-01-29 | 2005-01-20 | Magnus Pfahl | Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
| HUP0304096A2 (hu) * | 2003-12-19 | 2005-08-29 | Richter Gedeon Vegyészeti Gyár Rt. | Eljárás pioglitazon hidrogénklorid előállítására és intermedierjei |
| EP1716144A2 (de) * | 2004-02-20 | 2006-11-02 | Synthon B.V. | Verfahren zur herstellung von pioglitazon und verbindungen des verfahrens |
| US7435741B2 (en) * | 2006-05-09 | 2008-10-14 | Teva Pharmaceutical Industries, Ltd. | 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| WO2008128126A1 (en) * | 2007-04-11 | 2008-10-23 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) * | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| WO2008142706A2 (en) * | 2007-05-18 | 2008-11-27 | Matrix Laboratories Ltd | Novel process for the synthesis of pioglitazone and its salts thereof |
| JP2009023572A (ja) * | 2007-07-23 | 2009-02-05 | Hitachi Ltd | 移動車両 |
| US20090118514A1 (en) * | 2007-11-06 | 2009-05-07 | Raghupathi Reddy Anumula | Processes for preparing pioglitazone and its pharmaceutically acceptable salts |
| MX2011009384A (es) | 2009-03-11 | 2011-10-11 | Omeros Corp | Composiciones y metodos para profilaxis y tratamiento de adicciones. |
| AU2011207210A1 (en) | 2010-01-22 | 2012-08-16 | Dana-Farber Cancer Institute, Inc. | Compositions,kits, and methods for identification, assessment, prevention, and therapy of metabolic disorders |
| US20120094959A1 (en) | 2010-10-19 | 2012-04-19 | Bonnie Blazer-Yost | Treatment of cystic diseases |
| WO2012153312A1 (en) | 2011-05-11 | 2012-11-15 | Ranbaxy Laboratories Limited | Process for the purification of pioglitazone |
| JP2013241361A (ja) * | 2012-05-21 | 2013-12-05 | Tokuyama Corp | ５−ベンジル−２，４−チアゾリジンジオン誘導体の製造方法 |
| EP2914250B1 (de) | 2012-11-05 | 2018-04-04 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Kombination aus einem antikrebsmittel wie einem tyrosinekinaseinhibitor und einem stat5-antagonisten, vorzugsweise einem thiazolidindion, zur entfernung von hämatologischen krebsstammzellen in vivo und zur verhinderung eines blutkrebsrezidivs |
| JP6060916B2 (ja) | 2014-02-12 | 2017-01-18 | マツダ株式会社 | 自動車の前部整流構造 |
| WO2016071727A1 (en) | 2014-11-04 | 2016-05-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the prevention and the treatment of rapidly progressive glomerulonephritis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4582839A (en) * | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
| CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
-
1987
- 1987-07-14 US US07/073,695 patent/US4812570A/en not_active Expired - Lifetime
- 1987-07-20 EP EP19870306425 patent/EP0257781B1/de not_active Expired - Lifetime
- 1987-07-20 AT AT87306425T patent/ATE67497T1/de not_active IP Right Cessation
- 1987-07-20 ES ES198787306425T patent/ES2037718T3/es not_active Expired - Lifetime
- 1987-07-20 DE DE8787306425T patent/DE3773089D1/de not_active Expired - Lifetime
- 1987-07-23 JP JP62184859A patent/JP2611244B2/ja not_active Expired - Lifetime
- 1987-07-23 KR KR1019870008026A patent/KR950008312B1/ko not_active Expired - Lifetime
- 1987-07-24 HU HU873411A patent/HU198043B/hu unknown
-
1988
- 1988-12-29 US US07/291,782 patent/US4898947A/en not_active Ceased
-
1991
- 1991-12-18 GR GR91402068T patent/GR3003381T3/el unknown
-
1997
- 1997-10-10 US US08/948,515 patent/USRE36575E/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2611244B2 (ja) | 1997-05-21 |
| JPS63139182A (ja) | 1988-06-10 |
| USRE36575E (en) | 2000-02-15 |
| US4812570A (en) | 1989-03-14 |
| GR3003381T3 (en) | 1993-02-17 |
| US4898947A (en) | 1990-02-06 |
| ES2037718T3 (es) | 1993-07-01 |
| HU198043B (en) | 1989-07-28 |
| EP0257781A1 (de) | 1988-03-02 |
| EP0257781B1 (de) | 1991-09-18 |
| HUT47571A (en) | 1989-03-28 |
| KR950008312B1 (ko) | 1995-07-27 |
| KR880001647A (ko) | 1988-04-25 |
| DE3773089D1 (de) | 1991-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3773089D1 (de) | Verfahren zur herstellung von thiazolidinedion-derivaten. | |
| AU536686B2 (en) | 1,3-dioxolen-2-one derivatives | |
| KR870003086A (ko) | 설포닐우레아 유도체의 제조방법 | |
| ATE60334T1 (de) | Chinazolinonderivat und verfahren zu seiner herstellung. | |
| KR870002056A (ko) | 치환된 프로파르길옥시아세토니트릴 유도체의 제조 방법 | |
| ATE47138T1 (de) | Verfahren zur herstellung von 1,2-dithiolan-3pentans|ure (thioctsaeure). | |
| KR830007686A (ko) | 세팔로 스포린 유도체의 제조방법 | |
| ATE31309T1 (de) | Verfahren zur herstellung von 4-hydroxy-2-methyln-2-pyridyl-2h-1,2-benzothiazin-3-carboxamid 1,1- dioxid. | |
| ATE117314T1 (de) | Verfahren zur herstellung von o2,2'-anhydro-1- (beta-d-arabinofuranosyl)thymin. | |
| ATE115567T1 (de) | Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen. | |
| ATE68469T1 (de) | Verfahren zur herstellung von alkylpyruvaten. | |
| NO832667L (no) | Fremgangsmaate ved fremstilling av 7alfa-acylthio-15,16-methylen-3-oxo-17alfa-pregna-1,4-dien-21,17-carbolactoner | |
| ATE63109T1 (de) | Verfahren zur herstellung von isothiazolonen. | |
| ES8100238A1 (es) | Un procedimiento para la preparacion de derivados del acido oxisustituido-ciclohexilacetico | |
| KR890002011A (ko) | 5-할로 게노-6-아미노-니코틴산 할라이드. 이의 제조방법 및 용도 | |
| DE69007203D1 (de) | Imidazolderivate, Verfahren zu deren Herstellung und diese enthaltende Antiulkusmittel. | |
| KR860002486A (ko) | 티아진포스폰산 유도체의 제조방법 | |
| ATE59375T1 (de) | Verfahren zur herstellung von polyenaldehyden. | |
| KR840004720A (ko) | 살충제 조성물 및 이의 제조방법 | |
| ATE104975T1 (de) | Verfahren zur herstellung von imidazol-derivaten. | |
| LU88287I2 (fr) | Cyproternacetate (Climen) | |
| DE69127396D1 (de) | Verfahren zur Herstellung von Dihydrofuranonderivaten | |
| KR860002473A (ko) | 4-메틸-5-티오포름아미디노메틸이미다졸 디하이드로클로라이드의 제조방법 | |
| KR840006242A (ko) | 헤테로사이클 화합물의 제조방법 | |
| KR830006315A (ko) | 티아졸리노트리아진 유도체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EETV | Partially withdrawn | ||
| EELA | Cancelled due to lapse of time |